Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not

American Journal of Neuroradiology

Volumn 27, Issue 4, 2006, Pages 859-867

  Boxerman, Jerrold L ^a   Schmainda, K M ^b   Weisskoff, R M ^c,d  

^a BROWN UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Fidelity Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN MAPPING; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ERROR; EXTRAVASATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; TISSUE NECROSIS; BLOOD VOLUME; BRAIN TUMOR; CONTRAST MEDIUM EXTRAVASATION; GLIOMA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VOLUME; BRAIN MAPPING; BRAIN NEOPLASMS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 33748084051     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sugahara T, Korogi Y, Kochi M, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22:1306-15
2. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-98
3. Lam WW, Chan KW, Wong WL, et al. Pre-operative grading of intracranial glioma. Acta Radiol 2001;42:548-54
4. Kremer S, Grand S, Remy C, et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002;29:105-13
5. Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845-53
6. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-55
7. Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol 2001;2:1-7
8. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783-89
9. Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7-14
10. Roberts HC, Roberts TP, Bollen AW, et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001;8:384-91
11. Tzika AA, Astrakas LG, Zarifi MK, et al. Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 2003;45:1-10
12. Wu WC, Chen CY, Chung HW, et al. Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma. AJNR Am J Neuroradiol 2002;23:1775-78
13. Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189-200
14. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119-22
15. Kremer S, Grand S, Berger F, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003;45:44-49
16. Siegal T, Rubinstein R, Tzuk-Shina T, et al. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997;86:22-27
17. Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 2000;21:881-90
18. Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 2001;51:478-82
19. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11
20. Papadimitriou JM, Woods AE. Structural and functional characteristics of the microcirculation in neoplasms. J Pathol 1975;116:65-72
21. Hacklander T, Hofer M, Reichenbach J, et al. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors]. Rofo 1995;163:484-89
22. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-74
23. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65
24. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528-37
25. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68
26. Weisskoff RM, Boxerman JL, Sorensen AG, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the Society of Magnetic Resonance, Second Annual Meeting; 1994 Aug 6-12: San Francisco, Calif.; Berkeley, Calif: Society of Magnetic Resonance; 1994:279
27. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-73
28. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29
29. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147-57
30. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797-803
31. Vonken EJ, van Osch MJ, Bakker CJ, et al. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109-17
32. Vonken EP, van Osch MJ, Bakker CJ, et al. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000;43:820-27
33. Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22:1915-19
34. Enochs WS, Harsh G, Hochberg F, et al. Improved delineation of human brain tumors on MR images using along-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999;9:228-32
35. Boxerman JL, Hamberg LM, Rosen BR, et al. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-66
36. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
37. Schmainda KM, Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524-32
38. Deane BR, Lantos PL. The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. [Neural Sci 1981;49:55-66
39. Zama A, Tamura M, Inoue HK. Three-dimensional observations on microvascular growth in rat glioma using a vascular casting method. J Cancer Res Clin Oncol 1991;117:396-402
40. 2*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51:961-68
41. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656-66
42. Wagner ML, Ulmer JL, Rand SD, et al. Relationship between contrast enhancement and brain tumor neovascularity revealed by blood volume functional imaging. In: ASNR American Society of Neuroradiology 42nd Annual Meeting; 2004 Jun 5-11; Seattle, Wash; Oak Brook, Ill: American Society of Neuroradiology; 2004:18
43. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-65
44. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metab 1984;4:633-34
45. Weisskoff RM, Chesler D, Boxerman JL, et al. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-58
46. Thompson H, Starmer C, Whalen R, et al. Indicator transit time considered as a gamma variate. Circ Res 1964;14:502-15
47. Larsson H, Stubgaard M, Frederiksen J, et al. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-31
48. Donahue KM, Burstein D, Manning WJ, et al. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-76
49. Quirk JD, Bretthorst GL, Duong TQ, et al. Equilibrium water exchange between the intra- and extracellular spaces of mammalian brain. Magn Reson Med 2003;50:493-99